Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Biomarin Pharmaceut (BMRN)

87.29 -1.91 (-2.14%)

7/27/2017  2:37pm

Open:

89.14

Pre. Close:

89.20

High:

89.77

Low:

86.75

Volume:

1,053,790

Market Cap:

15.23B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

90.27 - 91.39

91.39 - 92.33

Low:

86.16 - 86.95

86.95 - 87.61

Close:

87.84 - 89.38

89.38 - 90.67

Technical analysis  (as of: 2017-07-27 2:05:59 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 110.58     One year: 116.84

Support:

Support1: 86.01    Support2: 71.56

Resistance:

Resistance1: 94.67    Resistance2: 100.03

Pivot:

89.06

Moving Averages:

MA(5): 88.87     MA(20): 89.46

MA(100): 90.45     MA(250): 89.96

MACD:

MACD(12,26): -0.77     Signal(12,26,9): -0.65

%K %D:

%K(14,3): 38.95     %D(3): 49.17

RSI:

RSI(14): 42.98

52-Week:

High: 102.49  Low: 78.42  Change(%): -12.3

Average Vol(K):

3-Month: 118766  10-Days 91052

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
BMRN has closed above bottom band by 19.7%. Bollinger Bands are 26.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 27 Jul 2017 12:00:00 GMT
Can BioMarin (BMRN) Keep the Earnings Streak Alive in Q2?

Tue, 18 Jul 2017 20:26:15 GMT
BioMarin to Host Second Quarter 2017 Financial Results Conference Call and ...

Tue, 11 Jul 2017 21:00:00 GMT
Biomarin Hemophila A Candidates Looks To Impress The Community

Tue, 18 Jul 2017 12:30:46 GMT
Sarepta Therapeutics and BioMarin Pharmaceutical Inc. Announce Execution of a ...

Fri, 30 Jun 2017 13:12:45 GMT
BioMarin Submits Pegvaliase Biologics License Application (BLA) to the US FDA ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

174.49

Shares Float (M)

173.44

% Held by Insiders

0.17

% Held by Institutions

100.00

Shares Short (K)

7690

Shares Short Prior Month (K)

7480

Stock Financials

EPS

-3.360

EPS Est. Current Year

-0.850

EPS Est. Next Year

-0.490

EPS Est. Next Quarter

-0.240

Forward EPS

-0.490

Book Value (p.s.)

15.980

PEG Ratio

-2.22

Profit Margin

-47.59

Operating Margin

-16.68

Return on Assets (ttm)

-3.2

Return on Equity (ttm)

-22.3

Qtrly Rev. Growth

28.3

Gross Profit (p.s.)

5.199

Sales Per Share

EBITDA (p.s.)

-0.572

Qtrly Earnings Growth

Operating Cash Flow (M)

-136.83

Levered Free Cash Flow (M)

-266.95

FoxReading.com

Valuation

P/E

-25.96

P/E Growth Ratio

-0.02

P/BV

5.46

P/S

2171541760.00

P/CF

-111.25

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.